Inovio to present at the oppenheimer 33rd annual healthcare conference

Plymouth meeting, pa. , march 3, 2023 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that jacqueline shea, ph.d.
INO Ratings Summary
INO Quant Ranking